World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision: DSM-IV-TR. Washington, D.C.: American Psychiatric Association, 2000.
10.1046/j.1360-0443.2000.9556611.x
10.1016/0165-6147(92)90059-F
10.1016/S0166-2236(99)01447-2
10.1126/science.278.5335.52
10.1016/S0893-133X(00)00195-0
10.1046/j.1360-0443.2001.9611038.x
10.1146/annurev.psych.54.101601.145237
10.1016/S0006-3223(01)01269-0
10.1176/appi.ajp.159.10.1642
10.1111/j.1360-0443.1991.tb01754.x
10.1016/0009-9236(95)90162-0
10.1016/S0376-8716(01)00127-2
10.1016/S0376-8716(00)00153-8
10.1046/j.1360-0443.2003.00236.x
10.2165/00003495-200262050-00003
10.1146/annurev.psych.53.100901.135142
10.1111/j.1530-0277.2001.tb02217.x
10.1001/archpsyc.59.9.825
10.1111/j.1749-6632.2001.tb03557.x
10.1097/00004714-200008000-00008
Rao Y, 2000, Mol Pharmacol, 58, 747, 10.1124/mol.58.4.747
10.1016/S0168-9525(02)02719-1
10.2165/00003495-200262090-00004
10.1016/S0301-0082(02)00008-4
10.1016/S0140-6736(98)05021-1
10.1136/bmj.325.7374.1199
10.1001/archpsyc.58.10.917
Bolla KI, 2002, Neurology, 59, 1337, 10.1212/01.WNL.0000031422.66442.49
10.1016/S0163-7258(02)00254-1
10.1111/j.1530-0277.1998.tb05897.x
10.1056/NEJM199905133401907
10.1056/NEJM199802263380907
Weiss F, 2002, J Neurosci, 22, 3332, 10.1523/JNEUROSCI.22-09-03332.2002
Sarnyai Z, 2001, Pharmacol Rev, 53, 209
Farre M, 1997, J Pharmacol Exp Ther, 283, 164
10.1016/S0091-3057(96)00433-9
10.1056/NEJM199604113341507
10.1097/00004714-200008000-00010
10.1007/s00213-002-1131-1
Ernst T, 2000, Neurology, 54, 1344, 10.1212/WNL.54.6.1344
Everitt BJ, 2002, J Neurosci, 22, 3312, 10.1523/JNEUROSCI.22-09-03312.2002
Smith DE, Wesson DR. Benzodiazepines and other sedative-hypnotics. In: Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. 2nd ed. Washington, D.C.: American Psychiatric Press, 1999:239-50.
Abraham HD, McCann UD, Ricaurte GA. Psychedelic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1545-56.
10.1111/j.1360-0443.1991.tb01747.x
10.1016/S0896-6273(02)00972-8
10.1111/j.1360-0443.1991.tb01741.x
Kalivas PW. Neurocircuitry of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1357-66.
10.1016/S0014-2999(99)00372-6
Konipsky KL, Hyman SE. Molecular and cellular biology of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1367-79.
De Vries TJ, 2002, J Neurosci, 22, 3321, 10.1523/JNEUROSCI.22-09-03321.2002
Robbe D, 2001, J Neurosci, 21, 109, 10.1523/JNEUROSCI.21-01-00109.2001
Maldonado R, 2002, J Neurosci, 22, 3326, 10.1523/JNEUROSCI.22-09-03326.2002
Spanagel R. Behavioral and molecular aspects of alcohol craving and relapse. In: Maldonado R, ed. Molecular biology of drug addiction. Totowa, N.J.: Humana Press, 2002:295-313.
Volkow ND, Fowler JS. Application of imaging technologies in the investigation of drug addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1475-90.
Merlo E, Heidbreder C, Mugnaini M, Teneggi V. Molecular and behavioral aspects of nicotine dependence and reward. In: Maldonado R, ed. Molecular biology of drug addiction. Totowa, N.J.: Humana Press, 2002:315-38.
Picciotto MR, 2002, J Neurosci, 22, 3338, 10.1523/JNEUROSCI.22-09-03338.2002
10.1097/00001756-199810260-00012
Berrendero F, 2002, J Neurosci, 22, 10935, 10.1523/JNEUROSCI.22-24-10935.2002
10.1080/105504901750532094
Taylor DA, 2001, J Pharmacol Exp Ther, 297, 11
10.1016/S0092-8674(02)00613-X
10.1126/science.278.5335.58
Rasmussen K, 1990, J Neurosci, 10, 2308, 10.1523/JNEUROSCI.10-07-02308.1990
Caille S, 1999, J Pharmacol Exp Ther, 290, 881
10.1111/j.1360-0443.1992.tb02001.x
10.1016/S0166-2236(02)02289-0
10.1016/S0896-6273(03)00021-7
10.1097/00019052-200012000-00017
10.1002/1098-2396(20010301)39:3<257::AID-SYN1007>3.0.CO;2-1
10.1016/S0896-6273(00)81056-9
Duman RS, 2001, J Pharmacol Exp Ther, 299, 401
10.1056/NEJM200011023431802
10.1016/S0376-8716(01)00171-5
